xFOREST Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

xFOREST Therapeutics General Information

Description

Developer of RNA-targeted small-molecule therapeutics designed to modulate RNA structure and splicing in diseases not addressed by conventional approaches. The company offers discovery platforms for screening selective RNA-structure binders and splicing modulators, enabling pharmaceutical partners and internal research teams to identify targeted RNA interactions and advance therapeutic development across multiple disease areas.

Contact Information

Website
www.xforestx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Creation Core Kyoto Gosha 214
  • 448-5 Kajiicho, Kamigyo-Ku
  • Kyoto, Kyoto 602-0841
  • Japan
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Creation Core Kyoto Gosha 214
  • 448-5 Kajiicho, Kamigyo-Ku
  • Kyoto, Kyoto 602-0841
  • Japan

xFOREST Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

xFOREST Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 26-Feb-2026 Completed Generating Revenue
7. Accelerator/Incubator 03-Sep-2025 Completed Generating Revenue
6. Later Stage VC (Series A) 24-Jan-2025 Completed Generating Revenue
5. Accelerator/Incubator 16-Feb-2024 Completed Generating Revenue
4. Accelerator/Incubator 12-Dec-2023 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Seed Round 31-Oct-2020 $1.27M $1.27M Completed Generating Revenue
1. Accelerator/Incubator 01-Mar-2019 Completed Generating Revenue
To view xFOREST Therapeutics’s complete valuation and funding history, request access »

xFOREST Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class A-2 Preferred Shares
Class A Preferred Shares
To view xFOREST Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

xFOREST Therapeutics Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

xFOREST Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7716055-B2 Method for analyzing higher-order structure of rna Active 29-Mar-2021
US-20240018583-A1 Method for analyzing higher-order structure of rna Pending 29-Mar-2021
WO-2022209428-A1 Method for analyzing higher-order structure of rna Inactive 29-Mar-2021
CA-3200114-A1 Rna probe for mutation profiling and use thereof Active 18-Nov-2020
CA-3200114-C Rna probe for mutation profiling and use thereof Active 18-Nov-2020 C40B40/06
To view xFOREST Therapeutics’s complete patent history, request access »

xFOREST Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

xFOREST Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
MEDISO Accelerator/Incubator
Miyako Capital Venture Capital Minority
J-Startup Accelerator/Incubator Minority
ANRI Venture Capital Minority
Takeda Pharmaceutical Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

xFOREST Therapeutics FAQs

  • When was xFOREST Therapeutics founded?

    xFOREST Therapeutics was founded in 2020.

  • Where is xFOREST Therapeutics headquartered?

    xFOREST Therapeutics is headquartered in Kyoto, Japan.

  • What is the size of xFOREST Therapeutics?

    xFOREST Therapeutics has 30 total employees.

  • What industry is xFOREST Therapeutics in?

    xFOREST Therapeutics’s primary industry is Drug Discovery.

  • Is xFOREST Therapeutics a private or public company?

    xFOREST Therapeutics is a Private company.

  • What is xFOREST Therapeutics’s current revenue?

    The current revenue for xFOREST Therapeutics is .

  • How much funding has xFOREST Therapeutics raised over time?

    xFOREST Therapeutics has raised $7.31M.

  • Who are xFOREST Therapeutics’s investors?

    MEDISO, Miyako Capital, J-Startup, ANRI, and Takeda Pharmaceutical are 5 of 7 investors who have invested in xFOREST Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process